Aasld Idsa Hcv Guidance Panel
Hepatology · 2015
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 24 citations into it; #78 of 151 by trust here, #145 by citations
- Epidemiology — 13 citations into it; #1,444 of 2,148 by trust here, #1,834 by citations
Whom Aasld Idsa Hcv Guidance Panel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Aasld Idsa Hcv Guidance Panel overall
Papers from Aasld Idsa Hcv Guidance Panel's perspective
Ordered by how strongly the researchers Aasld Idsa Hcv Guidance Panel trusts endorse each paper. Same corpus, a different order for every researcher.
- Sofosbuvir for previously untreated chronic hepatitis C infection. (New England Journal of Medicine)
- Sampling variability of liver fibrosis in chronic hepatitis C (Hepatology)
- ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. (New England Journal of Medicine)
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive… (The Lancet)
- Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. (Journal of the American Medical Association (JAMA))
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma (Annals of Internal Medicine)
- Management of hepatocellular carcinoma: An update (Hepatology)
- Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. (New England Journal of Medicine)
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. (New England Journal of Medicine)
- Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (Annals of Internal Medicine)